Stanford University Medical Center_Site number 143 — Palo Alto, California

Stanford University Medical Center_Site number 143 is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

Stanford University Medical Center_Site number 143 has participated in 1 clinical trials.

Therapeutic areas: System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Sponsors: Kadmon, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palo Alto

Browse all research sites in California · View every site in Palo Alto

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford University Medical Center_Site number 143?

Stanford University Medical Center_Site number 143 has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford University Medical Center_Site number 143 conducted?

Stanford University Medical Center_Site number 143 has 1 clinical trials on record. Their work covers System; Sclerosis, Diffuse Cutaneous Systemic Sclerosis.

Is Stanford University Medical Center_Site number 143 accredited by Crixeo Clinical Trials?

Stanford University Medical Center_Site number 143 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford University Medical Center_Site number 143?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.